KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction
- 1 December 2006
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 351 (1), 216-222
- https://doi.org/10.1016/j.bbrc.2006.10.022
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathwayNature, 2006
- A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 ActivationCell Cycle, 2005
- Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5Journal of Biological Chemistry, 2004
- Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation InhibitionMolecular and Cellular Biology, 2004
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteinsGenes & Development, 2002
- Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2α subunit of NuRDGenes & Development, 2001
- MDM2 — master regulator of the p53 tumor suppressor proteinGene, 2000
- Two Novel Krüppel-associated Box-containing Zinc-finger Proteins, KRAZ1 and KRAZ2, Repress Transcription through Functional Interaction with the Corepressor KAP-1 (TIF1β/KRIP-1)Published by Elsevier BV ,1999